Latest 8-K filings

OFA Group is implementing a 1-for-10 share consolidation to maintain its listing on the Nasdaq Capital Market, effective July 31, 2026.

Hope Bancorp announced a 12% quarter-over-quarter increase in net income for Q2 2026, driven by loan growth and margin expansion, and declared a quarterly dividend.

Spruce Biosciences announced the appointment of Dr. Adrian Quartel as its new Chief Medical Officer, effective July 27, 2026.

CytomX Therapeutics, Inc. announced the immediate appointment of Charles Fuchs, M.D., M.P.H., to its Board of Directors.

Alpha Metallurgical Resources announced preliminary Q2 2026 results, reporting a net loss and reducing annual shipment guidance due to market weakness and operational issues.

KIDZ AI Inc. issued an open letter to shareholders highlighting a significant gap between its share price and fundamental value, announcing an increase in its share repurchase program and reaffirming expected GPU compute revenue in Q4 2026.

NAVER, NVIDIA, and Brookfield announced plans to significantly expand South Korea's AI cloud infrastructure, increasing planned investment to 200 megawatts by 2028.

Cadiz Inc. has announced a Chief Financial Officer succession plan, with Jacinto J. Hernandez appointed as the new CFO and Stanley E. Speer retiring.

Strategy Inc. announced updates on its at-the-market (ATM) offering, share repurchase programs, and Bitcoin holdings as of July 26, 2026.

Alliance Resource Partners, L.P. announced robust second quarter 2026 financial and operating results, including a 33.9% increase in net income and a 14.7% rise in Adjusted EBITDA, driven by record oil & gas royalty revenues and improved coal operations.

Kyverna Therapeutics and ElevateBio have entered into a Clinical and Commercial Supply Agreement to secure manufacturing for Kyverna's lead cell therapy candidate, miv-cel.

Strive, Inc. announced a significant purchase of 79 bitcoin and provided an update on its cash, digital asset, and stock holdings as of July 24, 2026.

Arax Holdings Corp. announced the dismissal of Fruci & Associates II, PLLC as its independent auditor and the engagement of Shah Teelani & Associates as its new auditor, effective July 22 and July 23, 2026, respectively.

Vireo Growth Inc. announced its definitive agreement to acquire Planet 13 Holdings Inc. in a transaction valued at a premium to Planet 13's recent trading prices.

Precision BioSciences has appointed a new Chief Operating Officer and Chief Financial Officer, effective August 1, 2026, to support program advancement.

Boost Run Inc. is redeeming all outstanding warrants by August 20, 2026, with potential for significant cash proceeds if exercised.

Ponce Financial Group, Inc. announced robust financial results for the second quarter of 2026, showcasing significant growth in net interest income, loans, and deposits, alongside a strategic focus on preferred stock repurchase.

TransDigm Group announced a definitive agreement to acquire Prince & Izant, a maker of brazing alloys and specialty metal components, for approximately $1.066 billion.

Neumora Therapeutics announced favorable pre-clinical toxicology results for its obesity and cardiometabolic disease drug candidate, NMRA-215, with plans for clinical advancement.

MapLight Therapeutics announced positive topline results from its Phase 2 ZEPHYR trial of ML-007C-MA in schizophrenia, meeting its primary endpoint and showing a favorable safety profile.

XCF Global, Inc. has filed a preliminary proxy statement detailing proposals for a special meeting of stockholders related to a business combination agreement.

HBT Financial, Inc. announced robust financial results for the second quarter of 2026, driven by strong net interest income and effective integration of its CNB acquisition, leading to a dividend increase.

Expand Energy Corporation announced its definitive agreement to acquire Twin Eagle Holdings N.A., LLC for $1.25 billion, aiming to create North America's leading integrated natural gas company.

D-Wave Quantum Inc. announced an expanded agreement with AT&T to leverage quantum computing for complex network optimization challenges, aiming to enhance AI solutions and reduce downtime.

CAMP4 Therapeutics receives Australian regulatory clearance to initiate its Phase 1/2 clinical trial for CMP-002, a potential disease-modifying therapy for SYNGAP1-related disorder, and is eligible for up to $50 million in additional funding.

XPO, Inc. announced the appointment of Michael Kneeland to its Board of Directors, effective July 27, 2026, expanding the board to eight members.

Lakeland Financial Corporation presented its Q2 2026 investor materials, highlighting strong organic growth, a robust capital structure, and strategic initiatives focused on commercial banking and technology adoption.

Lakeland Financial Corporation announced record second quarter net income of $28.4 million, a 5% increase year-over-year, driven by revenue expansion and loan growth.

SPX Technologies announced the appointment of Brian Deck as an independent director to its Board of Directors, effective July 27, 2026, also assigning him to the Audit and Governance & Sustainability Committees.

Profusa, Inc. has appointed Jack Stover as Executive Chairman and CEO, Ben Hwang as President, and Liviu Goldenberg as a director, alongside signing a non-binding term sheet to acquire a commercial-stage health diagnostics and toxicology testing company.